It has been well established that RNA replication is initiated when a molecule of UMP is covalently linked to the hydroxyl group of a tyrosine (Y3) in VPg by the viral RNA polymerase 3D pol , but it is not yet known whether the substrate for uridylylation in vivo is the free peptide itself or one of its precursors. The aim of this study was to use complementation analyses to obtain information about the true in vivo substrate for uridylylation by 3D pol . Previously, it was shown that a VPg mutant, in which tyrosine 3 and threonine 4 were replaced by phenylalanine and alanine (3F4A), respectively, was nonviable. We have now tested whether wild-type forms of proteins 3B, 3BC, 3BCD, 3AB, 3ABC, and P3 provided either in trans or in cis could rescue the replication defect of the VPg(3F4A) mutations in the PV polyprotein. Our results showed that proteins 3B, 3BC, 3BCD, and P3 were unable to complement the RNA replication defect in dicistronic PV or dicistronic luciferase replicons in vivo. However, cotranslation of the P3 precursor protein allowed rescue of RNA replication of the VPg(3F4A) mutant in an in vitro cell-free translation-RNA replication system, but only poor complementation was observed when 3BC, 3AB, 3BCD, or 3ABC proteins were cotranslated in the same assay. Interestingly, only protein 3AB but not 3B and 3BC, when provided in cis by insertion of a wild-type 3AB coding sequence between the P2 and P3 domains of the polyprotein, supported the replication of the mutated genome in vivo. Elimination of cleavage between 3A and 3B in the complementing 3AB protein, however, led to a complete lack of RNA replication. Our results suggest that (i) VPg has to be delivered to the replication complex in the form of a large protein precursor (P3) to be fully functional in replication; (ii) the replication complex formed during PV replication in vivo is essentially inaccessible to proteins provided in trans, even if the complementing protein is translated from a different cistron of the same RNA genome; (iii) 3AB is the most likely precursor of VPg; and (iv) Y3 of VPg has an essential function in RNA replication in the context of both VPg and 3AB.
Poliovirus (PV), a member of the Picornaviridae virus family, replicates its plus-stranded genomic RNA in a tight association with membranous vesicles, which form upon PV infection and accumulate within the cell's cytoplasm (20) . Translation of the incoming plus-stranded RNA yields a polyprotein which contains one structural (P1) and two nonstructural (P2, P3) domains ( Fig. 1) . In a highly regulated cascade, a variety of precursor and mature proteins are proteolytically released from the polyprotein by virus-encoded proteinase 2A pro , 3C pro , or 3CD
pro (35, 36, 59 ). Many, if not all, of the nonstructural proteins and their precursors, as well as the viral RNA genome, make up the replication complex. This complex transcribes the parental viral RNA into complementary negative RNA strands which, in turn, serve as templates for the production of plus strands that are subsequently used for translation, replication, and encapsidation (46) .
The exact function of the replication complex is not known, but it is believed to be a platform for increased local concentrations of PV proteins and/or to serve as a scaffold for the assembly of their components (12, 20) . The replication complexes isolated from PV-infected cells appear as rosette-like assemblies of heterogeneously sized vesicles associated with viral nonstructural proteins and RNA (11, 12, 20) . It has been shown that a functional replication complex is formed in cis in a coupled process involving viral translation, membrane modification and vesicle budding, and viral RNA synthesis (19) . While many of the specific interactions involved in the replication complexes have been established, very little is known about the nature of the polypeptides that take part in the initial assembly of the complexes. Specific molecular interactions in the complexes have been shown to include cellular and viral proteins, viral RNA elements, and intracellular membranes: (i) the 5Ј-end cloverleaf structure of the PV genome interacts with viral protein 3CD pro either in a complex with cellular protein PCBP2 (4, 44) or with viral protein 3AB (26, 62) ; (ii) 3CD pro has also been shown to bind to the 3Ј nontranslated region (NTR) (26) and to an important cis-replicating element [cre(2C)] in the coding sequences of protein 2C
ATPase (63) ; (iii) protein 2C
ATPase interacts with the minus-strand cloverleaf of the PV genome (5, 6) and with cellular membranes (18) ; (iv) protein 3AB binds RNA nonspecifically (47) and also interacts with membranes (23) .
Complementation of lesions in the PV genome has been previously studied by providing the wild-type (wt) gene products in trans with helper viruses (59) or cell lines with a tran-sient-expression system (55) or in a novel approach, by using dicistronic (dc) PV (14) , during transfections. It has been clearly shown that capsid proteins can be provided in trans (15, 16, 33) ; however, the situation with the nonstructural proteins is more complicated (59) . Some lesions were reported to be complementable (1, 10, 14, 37, 56) , while others were not (10, 31, 55) . Based on the results of previous studies, the lack of complementation of certain replication lesions in PV has been explained either by the fact that the functions and properties of mature viral proteins differ from those of their precursors or by the fact that the complementing proteins lack access to the replication complex. Most recently, an in vitro cell-free translation-RNA replication system (41) has been used for complementation analysis (8, 17, 32, 56) . These in vitro reactions, which contain large amounts of input template RNA, produce saturating amounts of potential complementing proteins during translation, thus circumventing some of the problems related to the inaccessibility of proteins to the replication complex.
The proteins that are most directly involved in PV RNA synthesis are derived from the P3 domain of the polyprotein. The primary processing of the P3 domain yields two important and relatively stable precursors, 3AB and 3CD pro (36) (Fig. 1 ). Protein 3AB is believed to be the anchor of the RNA polymerase (3D pol ) to the membranes (29, 39, 60) , while 3CD pro possesses both proteinase (25, 36) and RNA binding activities (26, 44, 62, 63) . The two large precursors are then slowly processed into the mature proteins 3A, 3B, 3C pro , and 3D pol .
PV VPg(3B) is covalently linked to the 5Ј terminus of all newly synthesized viral RNAs via a phosphodiester bond between the conserved tyrosine residue at position 3 of VPg and the terminal UMP in the RNA genome (3, 54) . The 22-amino-acidlong VPg peptide has been shown to be essential for PV replication as the primer for RNA synthesis by 3D pol (49) . PV RNA replication is initiated when a molecule of UMP is covalently linked to tyrosine (Y3) in VPg (49) . This reaction is called VPg uridylylation and can be reproduced in vitro with two different assays depending on the templates used (48) (49) (50) 53) . The first assay uses poly(A) as a template and requires only 3D pol , synthetic VPg, UTP, and Mn 2ϩ (49, 50) . The products of the reaction are VPgpU, VPgpUpU, and VPg-linked poly(U). The second assay utilizes two purified viral proteins, 3D pol and 3CD pro , synthetic VPg, UTP, and Mg 2ϩ (Mn 2ϩ ) (48, 50, 53) . The template for the reaction is either PV RNA or an RNA hairpin, termed cre(2C), which is a segment of viral RNA located in the coding sequence of protein 2C
ATPase (24) . Studies using the in vitro translation-RNA replication system suggested that cre-dependent VPg uridylylation was only required for plus-strand RNA synthesis but not for minus-strand synthesis (43) . This conclusion remains controversial (58) . Although it is not yet known which template is used for uridylylation prior to minus-strand synthesis, the poly(A) tail has been proposed as a possible site (43, 49) .
The in vitro VPg uridylylation reaction has been thoroughly characterized (48-50, 53, 63) ; however, the exact form of VPg, which is used as a substrate for uridylylation in vivo, is still unknown. In the in vitro reaction with purified viral proteins, the optimal VPg concentration is 50-fold higher than that of the 3D pol , suggesting the possibility that one of the precursors of VPg is the true substrate for uridylylation in vivo (49 pol . In contrast, no uridylylation of 3AB, either membrane bound (22) or in a detergent solution (Paul and Wimmer, unpublished results), can be detected either on a poly(A) or a cre(2C) template in vitro.
The aim of this study was to obtain further information about the true substrate for uridylylation in vivo. To accomplish this goal, we have tried to rescue in vivo a lethal defect [VPg(3F4A)] in the polyprotein by providing potential complementing proteins (3B, 3AB, 3BC, 3BCD, and P3) either in trans (dc PV genomes [2, 14] or replicons) or in cis (by insertions between the P2 and P3 domains of the polyprotein). In these experiments, we only observed complementation by 3AB in cis, and even that rescue of function was poor. Elimination of cleavage between 3A and 3B in this complementing 3AB protein resulted in a complete lack of RNA replication. In addition, we tried complementation by 3AB, 3ABC, 3BC, 3BCD, and P3 of the same lethal mutations in the in vitro translation-RNA replication system and observed rescue of replication only by P3.
Our results, in agreement with previous studies by us and other investigators, indicate that the replication complex formed during PV replication in vivo is essentially inaccessible to proteins provided in trans. Furthermore, we found that VPg has to be delivered to the replication complex in the form of a large protein precursor (P3) to be functional in replication. Although we have not been able to determine the precise form of VPg that is uridylylated in vivo, our data suggest that 3AB is the precursor of VPg and that Y3 of VPg is required in vivo for RNA replication both in the context of VPg and of 3AB.
MATERIALS AND METHODS
Plasmids and cloning. Oligonucleotides used for PCRs are listed in Table 1 . (i) Construction of rV3-3B1(Y3F). We have previously constructed a PV cDNA clone that contained two 3B regions in tandem (13) . Both 3Bs contained a K/R change at position 10 of the VPg sequence ( Fig. 2A) , which had no effect on VPg function (13, 14) . To introduce the Y3F mutation in the 3B-1 region, two PCR fragments were made with primer pairs 14 and 23 and 22 and 19, using rV3 as a template (13) . The two resulting PCR fragments were mixed and used as templates in a new PCR with primer pair 14 and 19. This final product, MluI/ BglII cleaved, was transferred back into rV3 to make the rV3-3B1(Y3F) construct.
(ii) Construction of dc PV. We have previously constructed a dc PV (A2) with the genome structure of PV-5Ј NTR-EcoRI-encephalomyocarditis virus (EMCV)-internal ribosome entry site (IRES)-PV-open reading frame (ORF)-3Ј NTR-poly(A) and a full-length PV cDNA clone [pPVM-VPg(3F4A)] that carried the 3F4A mutations in VPg (14) . To replace the EcoRI site downstream of poly(A) of A2 with a SacI site, PCR mutagenesis was used with complementary primer pair 3 and 4 and A2 as the template. Primers 1 and 2 were used as the upstream and downstream primers. The resulting fragment, BglII/PvuI cleaved, was transferred back into A2 to make A2(SacI) with an unique EcoRI site. The MluI/BglII fragment of pPVM-VPg(3F4A) was used to replace that of A2(SacI) to make the construct of A2(3F4A). For the construction of DI3B-1/DI3B-2, a PCR fragment was made with primer pairs 5 and 6, using the cDNA clone (pPVM-2VPg-5) as the template (13) . The fragment was cut with EcoRI and cloned into an EcoRI-restricted A2(SacI) (for DI3B-1) or A2(3F4A) (for DI3B-2). The same strategy was used for making the constructs of DI3BC-1/DI3BC-2 with the primer pair 5 and 7.
(iii) Construction of dc luciferase replicons. To replace the P1 coding region with the luciferase gene in A2(SacI) and A2(3F4A), two PCR fragments were made with primer pairs 8 and 9 and 10 and 11, using A2(SacI) and a luciferase replicon P/L (wt) (38) as templates, respectively. The two resulting PCR fragments were mixed and used as templates in a new PCR with primer pair 8 and 11. This final product, EcoRI/SpeI cleaved, was transferred back into A2(SacI) and A2 (3F4A) to make replicons of P/E/F and P/E/F(3F4A), respectively. For the construction of DI-3BCD-1/DI3BCD-2, PCR fragments were made with primer pair 5 and 12 and the cDNA clone (pPVM-2VPg-5) as the template. The resulting fragment was cut with EcoRI and cloned into EcoRI-restricted A2(SacI)/A2(3F4A). For making DIP3-1/DIP3-2, two PCR fragments were made with primer pairs 13 and 24 and 25 and 12, using pPT7PVM and pPVM2VPg-5 as templates, respectively. The two resulting PCR fragments were mixed and used as templates in a new PCR with primer pair 13 and 12. This final product was cut with EcoRI and transferred back to an EcoRI-restricted A2(SacI)/A2(3F4A).
(iv) Construction of Cis3BC-1/Cis3BC-2, Cis3B-1/Cis3B-2, and Cis3AB-1/ Cis3AB-2/Cis3AB-2(CM). Cis3BC-1 and Cis3BC-2 contained an extra copy of 3BC coding sequence between the P2 and P3 coding regions in plasmids pT7PVM and pPVM-VPg(3F4A), respectively (14) . For constructing Cis3BC-1, three PCR fragments were made with primer pairs 14 and 15, 16 and 17, and 18 and 19 using pT7PVM, pPVM-2VPg-5, and pT7PVM as templates, respectively. The resulting three PCR fragments were mixed and used as templates in a new PCR with primer pairs 14 and 19. This final product, MluI/BglII cleaved, was transferred back into pT7PVM. The same primer pairs and templates, except that pPVM-VPg(3F4A) instead of pT7PVM was the template for primer pair 18 and 19, were used for making Cis3BC-2. The same strategy was used with primer pairs 14 and 15, 16 and 20, and 21 and 19 for making Cis3B-1 and Cis3B-2. Similarly, primer pairs 14 and 24, 25 and 20, and 21 and 19 were used to construct Cis3AB-1 and Cis3AB-2. To introduce the A-4E/Q-1H mutations in the wt 3AB region of Cis3AB-2, two PCR fragments were made with primer pairs 14 and 26 and 27 and 19, using Cis3AB-2 as a template. The resulting two PCR fragments were mixed and used as templates in a new PCR with primer pair 14 and 19. This final product, MluI/BglII cleaved, was transferred back into Cis3AB-2 to make Cis3AB-2(CM). to replace that of a PV luciferase construct P/L (38) , in which the P1 coding region is replaced with the luciferase gene, to make Cis3AB-2/L, Cis3AB-2(CM)/L, and 3F4A/L, respectively.
(vi) Construction of expression plasmid glutathione S-transferase (GST)-3AB(3F4A).
A PCR fragment containing the 3F4A mutations was generated with primer pair 28 and 29, using pPVM-VPg(3F4A) as a template. The PCR fragment was digested by SacI, treated with T4 polynucleotide kinase, and inserted between the PshAI and SacI sites of pET42b(ϩ) vector (Novagen).
(vii) Constructs used in in vitro translation-RNA replication reactions. Plasmid prib(ϩ)XpA containing a PV1(M) cDNA clone preceded by a hammerhead ribozyme was kindly provided by R. Andino (27) . In plasmids PVM(Rϩ) (wt) and PVM(Rϩ) (3F4A), the SnaBI/BglII fragment of prib(ϩ)XpA was replaced by that of pT7PVM and pPVM-VPg(3F4A), respectively. Sequences encoding wt proteins 3BC, 3BCD, 3AB, and 3ABC flanked by EcoRI sites and initiation/ termination codons were PCR amplified as described above ["(i) Construction of rV3-3B1(Y3F)" and "(ii) Construction of dc PV"]. A2 was digested with EcoRI to yield two fragments with lengths of 3,308 bp and of 6,781 bp. The 3,308-bp fragment that contained the pBR322 vector and the PV IRES sequences was ligated to PCR fragments of 3BC, 3BCD, 3AB, 3ABC, and P3 to generate plasmids p3BC, p3BCD, p3AB, p3ABC, and pP3.
Purification of GST-3AB protein harboring the 3F4A mutations. The protein was purified as described previously (22) . Briefly, Escherichia coli BL21 strain harboring the expression plasmid was grown in M9 media at 37°C to an optical density at 600 nm of 0.8. Isopropyl-␤-D-thiogalactopyranoside (IPTG; 0.5 mM) was then added to the culture, and protein expression was induced at 37°C for 3.5 h. The cell pellet was suspended in phosphate-buffered saline (PBS) containing 5% glycerol (vol/vol), 1 g/ml of leupeptin, and pepstatin A. Cells were lysed by sonication, and the lysate was centrifuged at 9,000 rpm in a Ty50.2 rotor for 20 min (Beckman L7-65 centrifuge). The supernatant was further centrifuged at 34,000 rpm for 1 h in the same rotor. The pellet was resuspended in PBS containing 5% glycerol (vol/vol), 1 g/ml of leupeptin, 1 g/ml of pepstatin A, 1 mM phenylmethylsulfonyl fluoride, 1 M NaCl, and 2% octylglucoside (wt/vol) and incubated at 4°C for 16 h to solubilize the membrane proteins. The lysate was centrifuged at 34,000 rpm in a Ty50.2 rotor for 1 h, and the supernatant was collected and applied to a glutathione-Sepharose column (Amersham Biosciences). Bound proteins were eluted in elution buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM CaCl 2 , 0.8% octylglucoside, 10 mM reduced glutathione).
Labeling of PV proteins in vivo. HeLa cell monolayers were infected with PV at a multiplicity of infection of 10, and at 30 min postinfection, actinomycin D was added to 5 g/ml. At 4.5 h postinfection, the cells were washed and resuspended in Dulbecco's modified Eagle medium lacking methionine. Thirty minutes later, [ 35 S]Translabel (10 Ci/ml; ICN) was added, and after a 30-min labeling period, the cells were washed and lysed.
GST pull-down assay. The GST pull-down assay was performed according to standard protocols. Briefly, 50-l aliquots of glutathione-Sepharose slurry were washed three times at 4°C in lysis buffer (PBS, 5% glycerol, 1 g/ml of leupeptin, 1 g/ml of pepstatin A, 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol). Five micrograms of purified GST-3AB(wt), GST-3AB(3F4A), or GST proteins was added and incubated for 2 h at 4°C. The protein-bound glutathioneSepharose beads were washed three times, and then 250 l 35 S-labeled PVinfected HeLa cell lysates were added. After 1 h of incubation at 4°C, the glutathione-Sepharose beads were washed three times and boiled in 1ϫ sodium dodecyl sulfate (SDS) sample buffer for 5 min. The samples were analyzed by SDS-polyacrylamide gel (12.5% acrylamide) electrophoresis and visualized by autoradiography.
In vitro transcription, transfection, and plaque assay. All plasmids were linearized with DraI. RNAs were synthesized with phage T7 RNA polymerase, and the RNA transcripts (5 g) were transfected into HeLa R19 cell monolayers by the DEAE-dextran method, as described previously (57) . The incubation time at 37°C was 12 h for luciferase replicons and up to 3 days for full-length viral constructs. Virus titer was determined by plaque assay (41) .
Western blot analysis. We ascertained the expression levels of translated protein by Western analysis. Samples of translation reactions were mixed with protein sample buffer and were subjected to SDS-polyacrylamide gel electrophoresis with 12.5% acrylamide. The proteins were transferred to a nitrocellulose membrane (Roche) with a SemiDry Trans Blot system (Bio-Rad). After blocking in 5% nonfat milk in PBS (pH 8.0) for 1 h, the membrane was incubated with primary anti-3B and anti-3C rabbit polyclonal antibodies. The membrane was washed three times with PBS (0.02% Tween 20) and was treated with a secondary antibody (alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G; Biosource). The membrane was rinsed again and then treated with 5-bromo-4-chloro-3-indolylphosphate (BCIP)/nitroblue tetrazolium tablets (Sigma) for visualization.
Reverse transcription-PCR and viral RNA sequencing. HeLa cell monolayers (5 ϫ 10 6 ) were infected with viruses that were obtained from RNA transfections with plaque purification, at a multiplicity of infection of 10. At 7 h postinfection, total cytoplasmic RNA was extracted with 500 l Trizol reagent (Invitrogen) and reverse transcribed into cDNA using the Superscript first-strand synthesis kit (Invitrogen). The PCR products were amplified with the primer pair 14 and 19
FIG. 2.
A free N terminus in VPg is required for RNA replication. (A) Nucleotide and amino acid sequences of wt 3B (3B-1, white) and heterologous 3B (3B-2, black) are shown. Note that the amino acid sequences of 3B-1 and 3B-2 are identical, but the nucleotide sequences are different to avoid homologous recombination. Both 3B-1 and 3B-2 have the 10th residue K of wt VPg changed to R, which has been shown to have no effect in viral RNA replication (14) . (B) Schematic representation of constructs rV3 and rV3-3B1(Y3F). The two tandemly arranged 3B regions are shown by rectangles. The wt cleavage site AKVQ/G between the two 3B sequences was changed to EKVQ/G in rV3. rV3-3B1(Y3F) contains the same cleavage site mutation and in addition an Y3F change in 3B-1. (C) RNA transcripts of the cDNAs were transfected into HeLa cells and the plaque phenotypes of the resulting viruses were determined by plaque assay (see Materials and Methods).
and then sequenced using the BigDye Terminator sequencing kit (ABI, Applied Biosystems).
Luciferase assays. After being transfected with replicon RNA, monolayer cultures (5 ϫ 10 6 ) of HeLa R19 cells were incubated at 37°C in standard tissue culture medium. After 12 h, the growth medium was removed from the dishes, and the cells were washed gently with 2 ml of PBS. HeLa cell dishes were overlaid with 300 l of passive lysis buffer (Promega) and rocked at room temperature for 15 min, after which the lysate was transferred to a tube. One hundred microliters of luciferase assay reagent (Promega) was mixed with 20 l of lysate, and the firefly luciferase activity was measured in an Optocomp I luminometer (MGM Instruments, Inc.).
Preparation of HeLa cytoplasmic extracts. HeLa S10 extracts were prepared as previously described (41) except for the following modifications: (i) packed cells from 2 liters of HeLa S10 were resuspended in 1.0 volume (relative to packed cell volume) of hypotonic buffer; (ii) the final extracts were not dialyzed.
Plus-and minus-strand RNA synthesis. Plus-and minus-strand RNA synthesis was determined as described previously (7, 9) . Translation-RNA replication reaction mixtures, programmed with viral RNA, were incubated for 4 h at 34°C in the presence of 2 mM guanidine HCl. The preinitiation replication complexes were resuspended in translation-RNA replication reaction mixtures lacking viral RNA in the presence of [␣-
32 P]CTP. The reaction mixtures were incubated at 34°C for 1 h, the labeled RNAs were separated by native agarose gel electrophoresis, and the products were visualized by autoradiography. Minus-strand RNA synthesis is determined by the amount of double-stranded RF (replicative form) RNA produced. Plus-strand RNA synthesis is measured by the amount of single-stranded RNA made. The reaction products were quantitated with a PhosphorImager (Molecular Dynamics Storm 800) by measuring the amount of [␣-
32 P]CMP incorporated into RNA.
RESULTS
The aim of these studies was to determine whether VPg or one of its precursors is the true substrate for uridylylation in vivo. To achieve this goal, we have tried a variety of strategies, both in vitro and in vivo, to complement a defect (3F or 3F4A) in PV VPg. Our previous studies have shown that a PV VPg mutant in which Y3 was replaced by F was quasi-infectious, but by the introduction of an additional mutation (T4A), the virus (3F4A) became nonviable (14) . It should be noted that the T4A mutation by itself has very little, if any, effect on PV replication (50) .
Exposure of a free N terminus of VPg is required for RNA replication in vivo. Our in vitro studies with purified proteins indicated that VPg, 3BC, and 3BCD can serve as substrates in poly(A)-or cre-dependent uridylylation reaction but 3AB cannot (Paul and Wimmer, unpublished results; Pathak and Cameron, unpublished results). This suggested the possibility that a free N terminus is required for VPg's function in uridylylation, and we designed an in vivo experiment to test this hypothesis. We have previously made the interesting observation that a genetically engineered PV containing two VPgs in tandem was quasi-infectious and, upon replication, it rapidly deleted the C-terminal VPg via homologous recombination (13) . This mechanism was eliminated in a variant in which the nucleotide sequence of one of the VPgs was engineered such that it differed 36% from that of the wt ( Fig. 2A) . Such viruses also expressed a quasi-infectious phenotype, and after the extended period of incubation, most retained both VPg sequences with extensive genetic alterations (deletions, mutations). Some of the progeny viruses contained mutations in the 3C pro -specific cleavage signal (AKVQ*G) between the two VPgs such that cleavage was unlikely or slow. One such variant, rV3, which possessed a nearly wt growth phenotype, contained an E instead of an A at the P-4 position of the cleavage site (EKVQ*G) and upon proteolytic processing of the P3 region of the polyprotein yielded 3AB1B2 and 3CD pro (13) . To test whether the exposure of the N terminus of VPg (3B) is required for function in vivo, we used the infectious cDNA clone of rV3 ( Fig. 2A and B) (13) . A Y3F mutation was introduced into 3B-1 to make rV3-3B1(Y3F) in which the possibility of uridylylating 3B-1 was eliminated. Transfection of the rV3-3B1(Y3F) RNA generated in vitro by T7 RNA polymerase onto HeLa cell monolayers did not yield any viable virus (Fig. 2C) . The fact that this mutation was lethal suggested that the tyrosine of 3B-2, which contained a Y residue in the context GAYT but had the blocked N terminus, could not be used as the substrate for uridylylation. These results are consistent with our in vitro data, obtained by using purified protein components, that a free N terminus in VPg is required for uridylylation. It should be noted, however, that the Y3F mutation in 3B-1 could also be detrimental to the function of 3AB in the context of the uncleaved 3AB1B2 precursor.
Inability of wt 3BC, 3BCD, 3AB, or 3ABC to complement the 3F4A mutations in an in vitro cell-free translation-RNA replication system. Recent studies have shown that in a cell-free HeLa translation-RNA replication system (41), viral replication proteins can be provided in trans to support RNA synthesis (8, 17, 21, 32, 56) . It is believed that in vitro with optimal concentrations of input template RNA the level of translation is relatively high from the beginning of incubation, and hence, complementation between viral proteins during the formation of the replication complex is more efficient than in vivo.
To minimize the problem created by the inaccessibility of trans-complementing proteins to the replication complex, we tried to rescue the VPg(3F4A) mutations in a PV genome in the cell-free translation-RNA replication reactions. We used PV cDNAs in which the PV sequence was preceded by a hammerhead ribozyme. These constructs yielded RNAs with the correct 5Ј-terminal nucleotide sequence (pUU. . .) following the removal of the two Gs from the transcripts made by T7 RNA polymerase (27) . Such transcripts, which have the same nucleotide sequence as PV mRNA, have been shown to replicate more efficiently in the in vitro translation-RNA replication cell extracts than uncleaved T7 RNA transcripts (27) . Complementing proteins were provided by cotranslating 3AB, 3ABC, 3BC, 3BCD, and P3 mRNA along with full-length PV transcript RNA containing the VPg(3F4A) mutations.
We first tested the ability of wt 3BC or 3BCD to transcomplement the replication defect of the 3F4A mutations in the cell-free translation-RNA replication reaction (41) . Wt and mutant (3F4A) PV transcript RNAs (7.7 nM) were either translated alone or in the presence of two concentrations of 3BC(D) mRNAs (3.6 nM, 7.2 nM) for 4 h. The initiation complexes were then isolated by centrifugation and resuspended in reaction mixtures lacking viral RNA but containing [␣-
32 P]CTP (7, 9) . After 1 h of incubation, the RNA products were applied to a nondenaturing agarose gel.
32 P-labeled minus-strand RNA products were measured as the doublestranded RF (Fig. 3A) and plus-strand RNA products were quantified as single-stranded RNAs (ssRNAs) (Fig. 3B) . Reactions containing wt PV transcript RNA in the presence of 2 mM guanidine HCl, a potent inhibitor of PV replication, were used as negative controls (Fig. 3A and B, lane 2) . As shown in Fig. 3 , only background levels of minus-and plus-strand RNA 3A and B, lanes 3 and 4 and lanes 5 and 6, respectively). The same results were obtained when wt 3AB or 3ABC was cotranslated with the full-length PV mutant (3F4A) transcript RNA ( Fig. 3C and D) . Neither minus-nor plus-strand RNA could be detected in the reaction mixtures with or without the potential complementing proteins. In contrast, P3 was the only polyprotein that showed efficient rescue of the lethal defect ( Fig. 4A and B, compare lanes 2 with lanes 3 and 4) . It should be noted that the complementing proteins were translated and processed normally in these reactions (data not shown). These results are similar to those of Towner et al. (56) , who showed that a replication-defective mutation in 3A could be complemented only by P3 but not by 3AB and suggested that, for efficient RNA replication to occur, VPg has to be delivered to the replication complex in the form of the large P3 precursor. Inability of wt 3B or 3BC to complement VPg(3F4A) in dc PV. Although it is generally accepted that the basic process of replication complex assembly is the same in the in vitro translation-RNA replication system as in vivo, it is also known that quantitative differences exist in the ability of the two systems to detect RNA replication. In vitro there is only a limited amount of RNA synthesis due to the fact that there is only a single cycle of growth. In vivo, however, very low levels of RNA replication in the course of a restricted growth cycle could eventually lead to robust RNA replication by the production of viable variants either in the first growth cycle or by subsequent passaging of infected cell lysates. For example, we have previously observed that in a dc (dc) PV, 3AB inserted into the first cistron was able to rescue the replication of a VPg(3F4A) mutant PV genome, even if only very poorly (14) . This suggested to us the possibility that, in the context of a dc PV, 3B or one of the other VPg precursors might also be functional, and possibly be more efficient, in rescuing the VPg mutations in the polyprotein. Therefore, we tried complementation of the 3F4A mutation in dc PV by 3B and 3BC. We constructed a dc PV, A2 [PV-5Ј NTR-EcoRI-EMCV-IRES-PV-ORF(wt)-3Ј NTR-poly(A)] (14), 32 P-labeled minus-strand RNA synthesis, measured as RF, was carried out as described in Materials and Methods. The autoradiography of the reaction products is shown, and the quantitation of the data is displayed below. (B) 32 P-labeled plus-strand ssRNA synthesis was measured as described in Materials and Methods. (C) 32 P-labeled minus-strand RNA synthesis, measured as RF, was carried out as described in Materials and Methods. (D) 32 P-labeled plus-strand ssRNA synthesis was measured as described in Materials and Methods. (Rϩ) indicates the presence of a ribozyme at the 5Ј terminus of the original transcripts (see text).
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and replaced the EcoRI site at the end of the poly(A) tail with a SacI restriction site [A2(SacI)] (Fig. 5A ). In the next step, we inserted the wt 3B and 3BC genes containing heterologous VPg sequences, produced through synonymous codons and flanked with initiation and termination codons, between the two IRES elements. This yielded dc PV DI3BC-1/-2 and DI3B-1/-2 (Fig. 5A) . The endogenous VPg of the polyprotein contained either the wt (3Y4T) sequence (DI3B-1, DI3BC-1) or the replication-defective mutant (3F4A) sequence (DI3B-2, DI3BC-2). Transfection of HeLa cell (R19) monolayers with DI3BC-1 RNA led to complete cytopathic effect (CPE) 40 h posttransfection at 37°C, about 10 h later than transfection with A2 or A2(SacI) RNAs and 16 h later than transfection with wt PV RNAs. The plaque sizes of viruses generated from A2 or A2(SacI) RNAs were small compared to the plaque size produced by wt PV RNA, and the plaques from DI3BC-1 were even smaller (Fig. 5B) . Similar results were observed with the dc construct DI3B-1. In contrast, no CPE was observed after transfection of HeLa cells with DI3BC-2 or DI3B-2 RNAs and 6 passages of the cell supernatants on HeLa cells. Our results showed that, in contrast to 3AB, neither 3B nor 3BC could complement the 3F4A defect in the polyprotein. We conclude that rescue of the 3F4A defect is so inadequate that replication of a quasi-infectious genome cannot be scored even when the complementing protein is translated from the same genome as the mutant protein. Moreover, a comparison of our results to those of Cao and Wimmer (14) indicates that only 3AB can rescue the 3F4A mutations in vivo in trans but 3B or 3BC cannot. Inability of wt 3BCD or P3 to complement VPg(3F4A) in dc luciferase replicons. dc PV cannot be used to test the complementation of VPg(3F4A) by 3BCD and P3 because the insertion of 3BCD (2,004 bp) or P3 (2,265 bp) in the first cistron would make the genomes 135% and 139% larger, respectively, than the wt PV genome. These large genomes are expected to reduce the efficiency of encapsidation (2, 30, 42) to such low levels that they would not be sufficient for virus production even if complementation were to occur. To overcome this problem, we constructed dc luciferase replicons in which the P1 domain of the PV genome was replaced by the coding sequences of the luciferase gene (Fig. 6A) , a strategy reminiscent of previous studies (38) . For testing complementation by P3 or 3BCD, the coding sequences of P3 or 3BCD were inserted between the PV and EMCV IRESs: [PV-5Ј NTR-3BCD/P3-EMCV-IRES-luciferase-P2-P3(3F4A)-3Ј NTR-poly(A)] (Fig. 6A) . The endogenous VPg in the polyprotein contained either wt (DI3BCD-1 and DIP3-1) or mutant (3F4A) sequences (DI3BCD-2 and DIP3-2). Transcript RNAs of the constructs were transfected onto HeLa cell monolayers, and the luciferase activities of the replicons were measured at 12 h posttransfection. As a control, background luciferase activity from the transfected RNA was measured in the presence of 2 mM guanidine HCl. Complementation efficiency was evaluated by comparing luciferase activities of replicons with and without wt 3BCD and P3 in the first cistron of the mutated dc genome. As shown in Fig. 6B , no complementation of VPg(3F4A) by 3BCD or P3 was detectable. DI3BCD-2 and DIP3-2 showed no increase in luciferase activities compared to the parental genomes (DI3BCD-1 and DIP3-1, respectively). Similarly, no complementation of VPg(3F4A) was observed in luciferase replicons by 3B or 3BC in the first cistron (data not shown). These results confirm our previous conclusion that replication complexes are essentially inaccessible to complementing proteins related to VPg precursors that are provided in trans even if they are derived from the same genome.
It should be noted that the 3F4A mutations did not cause trans-dominant negative effects on PV RNA replication in our experiments. We made dc luciferase replicons with 3B, 3BC, 3BCD, or P3 containing the VPg(3F4A) mutations inserted in the first cistron and wt polyprotein sequences in the second cistron. The luciferase activities exhibited by these replicons were essentially the same as what we observed with constructs DI3BCD-1 and DIP3-1, respectively (data not shown). The complementing proteins in the first cistron of dc viruses and dc replicons have been shown to be expressed well (data not shown).
Inability of wt 3B or 3BC to rescue the replication defect of VPg(3F4A) in cis. The lack of complementation in trans in dc constructs did not rule out the possibility that one or more of these proteins could rescue the 3F4A mutations in cis. We have previously shown that the insertion of a foreign coding se- quence (V3 loop of human immunodeficiency virus type 1 gp120) into the ORF of the polyprotein at the P2-P3 junction of PV genome yielded a virus that appeared to be genetically stable over several passages, suggesting that the insertion of a small peptide (47 amino acids) between P2 and P3 did not interfere with the correct folding of the large P2/P3 precursor and proteolytic processing between the two domains (51). Therefore, we constructed PV genomes in which the wt 3B and 3BC sequences (with heterologous 3B nucleotide sequences) were inserted in-frame at the P2-P3 junction of the polyprotein flanked by 3C
pro -specific cleavage sites [P1-P2-3B/3BC(wt)-3A-VPg(3F4A)-3CD] (Fig. 7A) . The VPg of the polyprotein contained either wt (Cis3B-1 and Cis3BC-1) or mutant (3F4A) sequences (Cis3B-2 and Cis3BC-2). Virus obtained from transfection of Cis3B-1 RNA exhibited a growth phenotype similar to that of wt PV. However, transfection of Cis3B-2 RNA did not yield viable virus (Fig. 7B) . Similarly, Cis3BC-1 showed a growth phenotype comparable to wt PV with slightly delayed CPE (36 h), whereas no viable virus was obtained by transfection of Cis3BC-2 RNA. To ensure that the lack of complementation was not due to a defect in protein processing, we translated the RNAs in HeLa cell extracts. Cis3B-1/Cis3BC-1 and Cis3B-2/Cis3BC-2 RNAs showed normal translation and processing of the polyprotein compared to wt PV RNA (data not shown). Since insertion of complementing proteins in cis would minimize the problem of inaccessibility to the replication complex, we can conclude that wt 3B and 3BC cannot rescue the defect in RNA replication. It should be noted that we did not test rescue in cis by 3BCD and P3 because of the expected genetic instability of the constructs caused by their large sizes.
Rescue of the replication defect of VPg(3F4A) by wt 3AB in cis. Our previous observation that wt 3AB was able to complement, albeit poorly, the VPg(3F4A) mutations in the polyprotein of a dc PV (14) suggested that 3AB might also rescue the defect in cis. Therefore, we inserted in-frame the wt coding sequences of 3AB (with heterologous 3B nucleotides sequences), flanked by 3C pro -specific cleavage sites, into the PV genome between the P2 and P3 domains of the polyprotein (Fig. 8A) . The VPg of 3AB in the polyprotein had either a wt (Cis3AB-1) or mutant (3F4A) (Cis3AB-2) sequence. Transfection of HeLa cells with Cis3AB-1 RNA yielded a virus with a growth phenotype comparable to that of the wt virus, although with slightly delayed CPE (32 h) (Fig. 8B) . In contrast, transfection of Cis3AB-2 RNA produced little, if any, CPE even after 2 to 3 days. However, upon the first passage of the cell lysates on HeLa cells, virus was produced with a plaque size comparable to that of the wt PV (Fig. 8B) . Different viral isolates were plaque purified and were used to reinfect fresh HeLa cells, after which the total cellular and viral RNAs were isolated from the cell lysates and were reverse transcribed. Sequencing of the viral genomes indicated that the second 3A sequence was completely deleted, while there were different deletions of the two VPg sequences (Fig. 8E) . In viruses 1 and 2, a single VPg of the expected length of 22 amino acids was regenerated from parts of the two tandemly arranged 3ABs. In virus 3, the first 19 amino acids of the first VPg were fused to amino acids 12 to 22 of the second VPg, yielding a 30-residuelong peptide. Interestingly, the VPg of this virus contained a repetition of amino acids 12 to 19 (NVPTIRTA). In this context, it should be noted that Cao and Wimmer (13) have also observed similar viral variants with longer than normal VPgs, which were derived from a PV genome containing two tandemly arranged heterologous VPgs. We also tested the possibility that the difference between the infectivity of Cis3AB-1 and Cis3AB-2 (Fig. 8 ) is due to a dominant-negative effect of the mutated VPg in the downstream 3AB of Cis3AB-2 by reversing the positions of the mutant and wt 3AB in the construct. The placement of 3AB with the 3F4A mutations in VPg upstream of the wt 3AB in the polyprotein had no effect on viral growth (data not shown).
Lack of rescue in cis by 3AB that contains cleavage site mutations between 3A and 3B. The observation that 3AB but not 3B or 3BC could rescue the 3F4A mutations in cis can be interpreted in different ways: (i) that in vivo 3AB (and not VPg or 3BC) is the substrate for uridylylation both for minus-and plus-strand RNA synthesis; (ii) that Y3 of VPg is required for RNA replication both in the context of 3AB and of VPg. To determine whether the rescue by 3AB was dependent upon proteolytic cleavage of 3AB, we introduced cleavage site mutations (A-4E/Q-1H) between 3A and 3B [Cis3AB-2(CM)] (Fig. 8A ) that totally abolished proteolytic processing of the inserted 3AB protein between P2 and P3 (data not shown). Transfection of such an RNA transcript into HeLa cells did not result in the production of viable virus even after several passages (Fig. 8B) . We also inserted 3AB with the cleavage site mutations at the junction of the P2 and P3 domains of the polyprotein in a luciferase replicon [Cis3AB-2(CM)/L] (Fig.  8C) . A luciferase replicon that contained wt 3AB (without the cleavage site mutations) between P2 and P3 (Cis3AB-2/L) (Fig. 8C) was used as the positive control. The negative control was a luciferase replicon of PV carrying the 3F4A mutations but without the additional 3AB sequence (3F4A/L) (Fig. 8C ).
As shown in Fig. 8C , the Cis3AB-2(CM)/L replicon did not produce a significant amount of luciferase signal compared to its positive control, Cis3AB-2/L (Fig. 8C) . These results and the observation that only the cleavable 3AB can rescue the defect suggest that Y3 of VPg has two distinct functions in RNA replication, one in the context of free VPg and the other in the context of 3AB. The latter conclusion is strongly supported by the following experiments. Y3 of VPg in 3AB is required for its interaction with 3D pol or 3CD pro . Our previous studies with yeast two-hybrid analyses have indicated that VPg and 3D pol strongly interact with each other (61) . One of the amino acids in VPg that is essential for complex formation with 3D pol is Y3 (50), whose hydroxyl group is the acceptor of UMP during the uridylylation reaction (49).
The results described above indicated that Y3 of VPg also has a function in PV replication in the context of 3AB. It is generally accepted that one of the functions of 3AB is to anchor 3D pol to membranes, and the interaction occurs primarily via the VPg domain of 3AB (60) . To test the possibility that an essential function of Y3 in the context of 3AB is to interact with 3D pol , we have carried out a GST pulldown assay with 35 S-labeled lysate from PV-infected cells and purified GST-3AB proteins containing VPg(3F4A) mutations (Fig. 8D) . Purified wt GST-3AB was used as a control (Fig. 8B, lane 2) . Our results clearly show that mutant (3F4A) 3AB proteins do not interact with either 3D pol or 3CD pro in this assay (Fig. 8D, lane 3) , an observation indicating that Y3 of VPg in 3AB is essential for the proteinprotein interaction.
DISCUSSION
Processing of the PV polyprotein occurs by a well-regulated but poorly understood cascade. The functions of intermediate cleavage products may be distinct from those of the end products of polyprotein processing, thereby providing the virus whose RNA is small with an enlarged number of functional proteins. The primary cleavage products of P3 are 3AB and 3CD pro , while alternate and slower processing cascades lead to the production of small amounts of the large precursors 3ABC (plus 3D pol ) and 3BCD (plus 3A) (35) . These large precursors are subsequently further processed to smaller precursors and mature viral proteins (Fig. 1) .
The aim of our studies was to learn more about the nature of the true substrate for uridylylation in vivo. To achieve this goal, we used both in vitro and in vivo complementation analyses of the lethal mutations (3F4A) in VPg. Studying complementation of mutations in the PV polyprotein is difficult because of the potential for inaccessibility of the complementing protein to the replication complex and because of the differences in the properties of the precursor and mature viral proteins. To interpret the results of any complementation study, one has to consider two important questions. First, can the potential complementing protein be incorporated into the replication complex? Second, can the protein in question overcome the replication defect(s) caused by the mutation in the polyprotein? Mutations such as 3F4A in VPg are expected to inhibit replication because Y3 of the peptide cannot function as a substrate residue for uridylylation. However, the same mutation might also interfere with one or more functions of the VPg precursors. Unfortunately, if the protein in question cannot be incorporated in trans into replication complexes for pol /3CD pro . The assay was carried out with purified GST-3AB(wt), GST-3AB(3F4A), and GST proteins, as described in Materials and Methods. (E) Genetic variants derived from the virus containing the extra copy of 3AB in cis. Viruses isolated from transfection with Cis3AB-2 RNAs were plaque purified, and the RNAs were isolated, reverse transcribed, and sequenced. complementation assays, then the second question cannot be addressed directly.
Previous results show that the in vitro translation-RNA replication system supports the complementation of mutant viral proteins in trans, and this suggests that under these conditions the problem of inaccessibility of complementing proteins to the replication complexes is less severe. Using such in vitro reactions, Towner et al. (56) have shown that a mutation in the hydrophobic domain of 3A in the PV polyprotein could be complemented by P3 with an active 3C pro proteinase domain but not by 3AB. These results were interpreted to mean that, for efficient RNA synthesis, 3A had to be delivered to the replication complex in the form of the large P3 precursor. We carried out similar in vitro experiments in which we attempted to complement the VPg(3F4A) mutations of the polyprotein by cotranslation of various proteins derived from P3. Although we use a mutant protein with mutations in 3B, our results are similar to those of Towner et al. (56) , that is, the VPg mutations could only be complemented by P3 and not by the smaller VPg precursors (3BC, 3BCD, 3ABC, and 3AB). Since VPg, just as 3A, has to be delivered to the replication complex in the form of the P3 precursor, these data do not allow us to draw any conclusions about the ability of the smaller P3-derived precursors to rescue the VPg(3F4A) mutations in RNA replication.
Although the in vitro translation-RNA replication system is very useful in the investigations of some aspects of PV RNA replication, it also has disadvantages compared to studying viral growth in vivo. One such disadvantage is that the in vitro system is not able to detect low levels of RNA replications, and the reason for this, at least in part, is that there is only one cycle of viral replication, whereas secondary infections are absent. In contrast, a very low level of RNA replication with a variant virus in the course of one replication cycle in vivo can lead to variants that eventually produce a viable virus via mutation and subsequent amplification, referred to as "quasi-infectious" virus. We have previously observed that in a dc PV, 3AB inserted in the first cistron was able to rescue the replication of a VPg(3F4A) mutant PV genome (14) . The initial dc genome was quasi-infectious, and the progeny contained various deletions and rearrangements. This suggested to us the possibility that 3B or one of the other VPg precursors might also be functional in rescuing the VPg mutations in the polyprotein by intragenomic complementation in vivo. Therefore, we tried complementation of the VPg(3F4A) mutations, contained in the PV polyprotein, in dc PV by wt 3B and 3BC. In addition, we attempted complementation of the defect with the large 3BCD and P3 precursors in dc replicons. Our results showed that neither 3B nor the other VPg precursors (3BC, 3BCD, or P3) could complement the 3F4A defect in the polyprotein. This observation indicates that complementation in trans is very poor and insufficient for rescue even when the complementing protein is translated from the same genome as the mutant protein. We speculate that the inability of P3 to complement in a dc replicon in vivo, in contrast to the in vitro system, is most likely related to lower levels of the complementing protein and the problem of in trans delivery of the complementing protein in vivo. One important conclusion drawn from these experiments, however, based on the results of Cao and Wimmer (14) , is that only 3AB but not VPg, 3BC, 3BCD, or P3 is able to rescue the mutations in vivo.
We also observed a striking difference in the ability of 3AB to rescue the 3F4A mutations in cis compared to 3B or 3BC. Insertion of 3AB between P2 and P3 yielded a quasi-infectious genome that was genetically unstable and deleted the second 3A and parts of both VPgs. In contrast, neither 3B nor 3BC inserted in cis was able to rescue the 3F4A mutations. It should be noted that under these conditions the experiments measured the effect of the complementing protein on RNA replication directly, since the problem with inaccessibility of the complementing protein to the replication complex is eliminated. At first glance, these results might be interpreted to mean that in vivo 3AB is the substrate for uridylylation rather than 3B or 3BC. There are, however, alternative hypotheses, which will be discussed later.
The observation that 3AB but not 3B and 3BC can rescue in cis the replication defect caused by the 3F4A mutations was surprising in view of our previous in vitro studies with purified proteins, which clearly show that 3AB cannot be uridylylated either on a poly(A) or a cre(2C) template, whereas VPg, 3BC, and 3BCD are excellent substrates in this reaction. To try to decipher these contradictory results, we have made both a PV genome and a PV luciferase replicon, which contained cleavage site mutations between the 3A and 3B domains of the complementing 3AB protein, inserted into the polyprotein in cis. The mutations abolished the ability of the replicon to make RNA and the ability of the mutant genome to produce viable PV. The fact that uncleavable 3AB does not rescue in cis indicates that at some point in replication this precursor has to be processed to 3A and VPg to be functional in RNA replication. Interestingly, Y3 of VPg in 3AB is essential for complex formation between 3AB and 3D pol or 3CD pro in vitro, as shown by our GST pull-down assays. This is not surprising in view of the fact that Y3 of free VPg is also required for this function (50) and VPg and 3AB have the same binding site on 3D pol (40) . The most plausible explanation of these results is that this interaction between 3AB and 3D pol /3CD pro is essential for RNA replication.
So far, all of the available data with purified proteins or VPg derived from membrane-bound 3AB in vitro by proteolytic cleavage by 3CD pro (22) indicate that a free N terminus in VPg (3BC, 3BCD) is required for the covalent attachment of UMP to the hydroxyl group of Y3. Although our studies suggest that VPg, derived from 3AB, is the substrate for uridylylation in vivo, they do not rule out the possibility that 3BC and 3BCD also have a function at some stage of RNA replication. However, we can already draw one important conclusion from these studies: that Y3 of VPg is required for RNA replication both in the context of VPg and 3AB. This suggests the possibility that in vivo Y3 in both VPg and 3AB may be used as the acceptor for UMP, possibly at different stages of RNA synthesis. Again, we have never observed uridylylation of either membranebound 3AB or 3AB in a detergent solution with either poly(A)-or cre(2C)-containing templates. Two possibilities may be cited as explanation: (i) we have not yet found the optimal condition for this reaction in vitro; (ii) additional proteins are required for this process. In this context, it should be noted that a recent report (52) described the in vitro uridylylation of 3AB with an A 15 template RNA but not with poly(A) or other larger RNAs.
These results were interpreted to mean that a 15-nucleotidelong single-stranded RNA binds only a single polymerase molecule, whereas longer RNAs have the capacity to bind multiple polymerase molecules cooperatively. If true, 3D pol oligomerization would be detrimental to the initiation of RNA synthesis if 3AB were the true substrate for uridylylation. This is contrary to available evidence (see below).
For many years, it has been generally assumed that 3D pol , which possesses no membrane anchor domain of its own, is bound to the membranes in a complex with 3AB. Recently we have shown that 3AB assumes a "hairpin" like configuration in membranes with free N and C termini (22) . This membranebound 3AB can be cleaved by 3CD pro in vitro (22, 34) , yielding 3A and VPg. It has also been shown that oligomerization of 3D pol is required for its functions in vitro in RNA binding (28) , polymerization (28) , and uridylylation (45) .
On the basis of our current experiments, we propose two possible models for the initiation of PV RNA replication that are not mutually exclusive and incorporate all of the abovementioned observations. Following cleavage of the polyprotein into P2 and P3, the large precursors are incorporated into membranous replication complexes. The major processing cascade of P3 leads to the production of some 3AB and 3CD pro , which is subsequently further processed into 3C pro and 3D pol . As depicted in Fig. 9 , a dimer (or oligomer) of 3D pol molecules is bound to the membranes in a complex with 3AB proteins (40) , and the Y3 of VPg in 3AB is involved in this process (50, 62) (Fig. 7D ). According to both models (A and B in Fig. 9 ), the role of Y3 in VPg in the context of 3AB is, in part, to promote interaction with 3D pol and thereby keep the polymerases attached to membranes during RNA replication (Fig.  9, step 1) . Subsequently, the two pathways differ only in the additional role of 3AB in RNA replication. The first model (A) (Fig. 9) proposes the cleavage of some of the membrane bound 3AB by 3CD pro to yield 3A and VPg (step 2), which is subsequently used as substrate for the uridylylation reaction (step 3). The resulting VPgpUpU serves as primer for 3D pol for initiation of RNA chains. According to the second model (B) (Fig.  9) , Y3 of VPg in 3AB is not only used for interaction with 3D pol but also as a substrate residue for uridylylation (step 2). Cleavage of uridylylated 3AB (3ABpUpU) by 3CD pro yields membrane bound 3A and VPgpUpU, the primer used for FIG. 9 . Two possible models for the initiation of PV RNA replication. In both models (A and B) the first step is the interaction of two molecules of membrane-bound 3AB with a dimer of 3D pol . One molecule of 3AB serves a structural function and anchors the dimer of 3D pol molecules to the membranes during the uridylylation reaction. In model A (shown by solid lines), the second molecule of 3AB is cleaved by 3CD pro to yield membrane-bound 3A and VPg (step 2) which is uridylylated by 3D pol to yield VPgpUpU (step 3). In model B (shown by broken lines), the second molecule of 3AB is uridylylated by 3D pol to yield 3ABpUpU (step 2). This precursor is cleaved by 3CD pro to 3A and VPgpUpU (step 3). The uridylylated VPg made in either pathway A or B is proposed to serve as primer for the elongation of RNA chains by 3D pol . Our models do not distinguish between the priming of plus and minus RNA strands.
RNA synthesis by 3D pol (step 3). It should be noted that our results do not allow us to make a clear-cut decision of which pathway is used for minus-or plus-strand RNA synthesis or for both but currently we favor model A. Further studies will be needed to fully understand the complex relationship between VPg and its precursors and their role in the protein priming reaction.
